Physician profile
Sally Dye
NPI 1154608032
$901.87
in general payments reported to CMS, 2019-2025
15 companies · $16.21 in 2025
The $16.21 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $367 · 2022: $269 · 2023: $178 · 2024: $71.20 · 2025: $16.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $191.07 | 2022-2025 | Amplatzer Amulet, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2021 | |
| Penumbra, INC. | $116.74 | 2021 | |
| Medtronic, INC. | $111.40 | 2021-2022 | |
| Teleflex LLC | $107.75 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.27 | 2023 | Lifevest |
| Edwards Lifesciences Corporation | $44.32 | 2021-2024 | Sapien 3 Ultra Resilia |
| Impulse Dynamics (USA) INC. | $34.06 | 2022 | |
| Shockwave Medical, INC | $21.11 | 2021 | |
| Livanova USA, INC. | $21.00 | 2023 | Protekduo |
| Cardiva Medical, INC. | $19.03 | 2022 | |
| Convatec INC. | $16.26 | 2022 | |
| Lilly USA, LLC | $14.17 | 2023 | Mounjaro |
| Boston Scientific Corporation | $13.51 | 2022 | |
| Ethicon US, LLC | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Dye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.